Al-Saadany et al. found significantly elevated serum IL-17 levels in patients with rheumatoid arthritis, with higher levels during active disease compared to stable phases, indicating its role in regulating inflammation and pathogenesis in these patients [32]. Here, IL17A is linked to rheumatoid arthritis.